Prostatype Genomics publishes Annual Report for 2022
Prostatype Genomics AB today publishes the Annual Report for the financial year of 2021. The Annual Report is attached as a PDF and is available on the company's webpage: www.prostatypegenomics.comThe company is the result of over fifteen years of research work in the genomics of prostate cancer. The company was founded in 2007 as a spin-off from Cancer Center Karolinska (Karolinska Institutet, Stockholm). The result was the development of the today CE-marked and market-ready product Prostatype® Test System. Prostatype® is a test for the prognosis of prostate cancer that has been developed